Inflammatory breast cancer appearance at presentation is associated with overall survival

被引:7
|
作者
Balema, Wintana [1 ,2 ,3 ]
Liu, Diane [4 ]
Shen, Yu [4 ]
El-Zein, Randa [5 ]
Debeb, Bisrat G. [1 ,6 ]
Kai, Megumi [2 ,3 ]
Overmoyer, Beth [7 ]
Miller, Kathy D. [8 ]
Le-Petross, Huong T. [2 ,3 ]
Ueno, Naoto T. [1 ,6 ]
Woodward, Wendy A. [1 ,2 ,3 ]
机构
[1] Univ Texas Hlth Sci Ctr Houston, Grad Sch Biomed Sci, Houston, TX 77030 USA
[2] Morgan Welch IBC Clin, Dept Radiat Oncol, Houston, TX USA
[3] Univ Texas MD Anderson Canc Ctr, Res Program, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[5] Houston Methodist Canc Ctr, Dept Radiol, Houston, TX USA
[6] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA
[7] Dana Farber Canc Inst, Boston, MA 02115 USA
[8] Indiana Univ Sch Med, Indianapolis, IN 46202 USA
来源
CANCER MEDICINE | 2021年 / 10卷 / 18期
关键词
breast cancer; breast swelling; erythema; IBC; peau d'orange; redness; skin thickening; T4D; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; CLINICAL MANAGEMENT; DIAGNOSIS; LYMPHANGIOGENESIS; CARCINOMA; CONSENSUS; CENTERS; PROGRAM; BIOLOGY; TIME;
D O I
10.1002/cam4.4170
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Inflammatory breast cancer (IBC) is a clinical diagnosis. Here, we examined the association of a "classic" triad of clinical signs, swollen involved breast, nipple change, and diffuse skin change, with overall survival (OS). Method Breast medical photographs from patients enrolled on a prospective IBC registry were scored by two independent reviewers as classic (triad above), not classic, and difficult to assign. Chi-squared test, Fisher's exact test, and Wilcoxon rank-sum test were used to assess differences between patient groups. Kaplan-Meier estimates and the log-rank test and Cox proportional hazard regression were used to assess the OS. Results We analyzed 245 IBC patients with median age 54 (range 26-81), M0 versus M1 status (157 and 88 patients, respectively). The classic triad was significantly associated with smoking, post-menopausal status, and metastatic disease at presentation (p = 0.002, 0.013, and 0.035, respectively). Ten-year actuarial OS for not classic and difficult to assign were not significantly different and were grouped for further analyses. Ten-year OS was 29.7% among patients with the classic sign triad versus 57.2% for non-classic (p < 0.0001). The multivariate Cox regression model adjusting for clinical staging (p < 0.0001) and TNBC status (<0.0001) demonstrated classic presentation score significantly associated with poorer OS time (HR 2.6, 95% CI 1.7-3.9, p < 0.0001). Conclusions A triad of classic IBC signs independently predicted OS in patients diagnosed with IBC. Further work is warranted to understand the biology related to clinical signs and further extend the understanding of physical examination findings in IBC.
引用
收藏
页码:6261 / 6272
页数:12
相关论文
共 50 条
  • [1] Why diagnosing inflammatory breast cancer is hard and how to overcome the challenges
    Le-Petross, Huong T.
    Balema, Wintana
    Woodward, Wendy A.
    CHINESE CLINICAL ONCOLOGY, 2021, 10 (06)
  • [2] Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer
    Diao, Jian-dong
    Ma, Li-xia
    Sun, Mei-yang
    Wu, Chun-jiao
    Wang, Li-juan
    Liu, Yan-ling
    Yang, Yong-jing
    CANCER MEDICINE, 2019, 8 (12): : 5600 - 5608
  • [3] Pathologic complete response and overall survival in breast cancer subtypes in stage III inflammatory breast cancer
    van Uden, Dominique J. P.
    van Maaren, Marissa C.
    Bult, Peter
    Strobbe, Luc J. A.
    van der Hoeven, J. J. M.
    Blanken-Peeters, Charlotte F. J. M.
    Siesling, Sabine
    de Wilt, Johannes H. W.
    BREAST CANCER RESEARCH AND TREATMENT, 2019, 176 (01) : 217 - 226
  • [4] Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis
    Tamer M. Fouad
    Takahiro Kogawa
    Diane D. Liu
    Yu Shen
    Hiroko Masuda
    Randa El-Zein
    Wendy A. Woodward
    Mariana Chavez-MacGregor
    Ricardo H. Alvarez
    Banu Arun
    Anthony Lucci
    Savitri Krishnamurthy
    Gildy Babiera
    Thomas A. Buchholz
    Vicente Valero
    Naoto T. Ueno
    Breast Cancer Research and Treatment, 2015, 152 : 407 - 416
  • [5] Expression of MicroRNA-9 is Associated With Overall Survival in Breast Cancer Patients
    Sporn, Judith C.
    Katsuta, Eriko
    Yan, Li
    Takabe, Kazuaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 233 : 426 - 435
  • [6] Overall survival and associated factors in women with metastatic breast cancer treated with trastuzumab at a public referral institution
    Goncalves, Debora Silva
    Migowski, Arn
    da Costa, Susanne Crocamo Ventilari
    da Costa, Rodrigo Saar
    Simoes e Senna, Katia Marie
    Zimmermann, Ivan Ricardo
    REVISTA BRASILEIRA DE EPIDEMIOLOGIA, 2023, 26
  • [7] Nomogram for predicting the overall survival of patients with inflammatory breast cancer: A SEER-based study
    Pan, Xingxi
    Yang, Wen
    Chen, Yongfa
    Tong, Lihua
    Li, Churong
    Li, Hui
    BREAST, 2019, 47 : 56 - 61
  • [8] Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study
    Parrish, Kendra M.
    Thomas, Samantha M.
    Cartwright, Sara B.
    van den Bruele, Astrid Botty
    Zasloff, Rebecca
    DiLalla, Gayle A.
    DiNome, Maggie L.
    Menendez, Carolyn S.
    Rosenberger, Laura H.
    Woriax, Hannah E.
    Hwang, E. Shelley
    Plichta, Jennifer K.
    Chiba, Akiko
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (12) : 8057 - 8067
  • [9] Prognostic Factors Associated With Overall Survival in Breast Cancer Patients With Metastatic Spinal Disease
    Soto, Gervith Reyes
    Cacho-Diaza, Bernardo
    Bravo-Reynab, Carlos
    Guerra-Mora, Jose Raul
    Ovalles, Carlos
    Catillo-Rangel, Carlos
    Ramirez, Manuel de Jesus Encarnacion
    Montemurro, Nicola
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (11)
  • [10] Physical activity in breast cancer survivors: A systematic review and meta-analysis on overall and breast cancer survival
    Spei, Maria-Eleni
    Samoli, Evangelia
    Bravi, Francesca
    La Vecchia, Carlo
    Bamia, Christina
    Benetou, Vassiliki
    BREAST, 2019, 44 : 144 - 152